Recognition poliovirus/HIV chimaeras antisera individuals HIV infection neutralization poliovirus/HIV serum HIV-infected individuals presentation HIV envelope sequences immune response individuals specific epitopes stage disease sera unable chimaeras Sabin vaccine strain fifth construct immunodominant sequence significant differential recognition individuals asymptomatic HIV infection groups II III Disease Control CDC classification HIV infection patients symptomatic disease CDC group IV patients CDC stage IV disease antibody levels construct titre progression disease AIDS-related complex ARC patients CDC group IVA AIDS group IV Loss antibody construct reduction anti-polio anti-envelope response decline antibody levels HIV sequence antigenic site 